Systematic review for the development of a pharmaceutical and medical products prioritization framework

• Published in: Journal of pharmaceutical policy and practice Vol. 12; no. 1; p. 21
• Main Authors: Frutos Pérez-Surio, Alberto, Gimeno-Gracia, Mercedes, Alcácera López, Ma Aránzazu, Sagredo Samanes, Ma Asunción, Pardo Jario, Ma Del Puerto, Salvador Gómez, Ma Del Tránsito
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 21-08-2019; BioMed Central; Taylor & Francis Group
• Subjects: Analysis; criteria resource allocation; Decision making; Ethics; Health policy; health priorities; Health technology assessment; medical products; Medical technology; Organizations; pharmaceuticals; Resource allocation; Short Report; Systematic review; Technology; Decision-making; Medical products; Criteria resource allocation; Health technology assessment; Health priorities; Pharmaceuticals
• DOI: 10.1186/s40545-019-0181-2
• EISSN: 2052-3211

To identify and analyze the criteria, approaches, and conceptual frameworks, used for national/international priority setting.
We performed a search of the main biomedical databases (Medline/PubMed, Embase, Centre for Reviews and Dissemination, and Cochrane), and we reviewed assessment agency websites, among other sources.
An systematic review of the literature was carried out.
Eligibility criteria for inclusion were based on set of predefined criteria. Systematic reviews and/or qualitative studies (interviews, surveys, expert consensus, etc) that aimed to identify prioritization criteria or develop general operational frameworks for the selection of health priorities were included. A critical analysis is made of all the aspects that may be useful for any public body that intends to establish priorities in health.
We found that there are no standardized criteria for priority setting, although common trends have been identified regarding key elements. Eight key domains were identified: 1) need for intervention; 2) health outcomes; 3) type of benefit of the intervention; 4) economic consequences; 5) existing knowledge on the intervention/quality and uncertainties of the regarding evidence; 6) implementation and complexity of the intervention/feasibility; 7) justice and ethics; and 8) overall context.
Our review provides a thorough analysis of the relevant issues and offers key recommendations regarding considerations for developing a national prioritization framework. Findings are envisioned to be useful for different public organizations that are aiming to establish healthcare priorities.